Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective comparison of adjunctive analgesic therapies for knee osteoarthritis
ChiCTR1800014977Phase 4Not yet recruiting
- Sponsor
- Hunan Provincial People's Hospital
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of buprenorphine, betamethasone and celecoxib in knee osteoarthritis (OA) (4 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: VAS score at 8 weeks and Lysholm score at 8 weeks. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
buprenorphinebetamethasonecelecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1800014977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014977.